Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration (Q44343394)

2 December 2017

title

Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration (English)

1 reference

2 December 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00226-0

30 March 2024

Andreas Moser

1 reference

2 December 2017

Ansgar Thümen

series ordinal

1 reference

2 December 2017

Fatimunnisa Qadri

series ordinal

1 reference

2 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607311

30 March 2024

publication date

1 December 2003

1 reference

2 December 2017

15 December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607311

full work available at URL

30 March 2024

https://api.elsevier.com/content/article/PII:S0022510X03002260?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0022-510X(03)00226-0

https://api.elsevier.com/content/article/PII:S0022510X03002260?httpAccept=text/plain

30 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0022-510X(03)00226-0

Journal of the Neurological Sciences

30 March 2024

published in

1 reference

2 December 2017

volume

216

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

109-112

1 reference

Ondansetron for hallucinosis in advanced Parkinson's disease

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Inhibition of type A monoamine oxidase by 2(N)-methyl-6,7-dihydroxyisoquinolinium ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

N-methyl-norsalsolinol modulates serotonin metabolism in the rat caudate nucleus: correlation with behavioural changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Molecular cloning and expression of a delta-opioid receptor from rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

The nucleotide sequence of the rat cytoplasmic β–actin gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

N-methyl-norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Serotonin 2A receptor mRNA levels in the neonatal dopamine-depleted rat striatum remain upregulated following suppression of serotonin hyperinnervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the rat striatum and globus pallidus: studies with fluoxetine and DOI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptides in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900226-0

Psychiatric side effects during the treatment of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0022-510X(03)00226-0

30 March 2024

Identifiers

DOI

1 reference

2 December 2017

1 reference